Trial intelligence / Profile preview

Ultrasound-guided subcostal anterior quadratus lumborum block ropivacaine dosing study

ChiCTR2500096318Phase 4Recruiting

Sponsor
Department of Anesthesiology, Affiliated Hospital of Yangzhou University
Start
Jan 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of ropivacaine in postoperative pain and postoperative abdominal discomfort, sponsored by Department of Anesthesiology, Affiliated Hospital of Yangzhou University. Primary endpoint: Subcostal anterior quadratus lumborum block plane range. Started Jan 2025; status: recruiting.

02

Drugs

ropivacaine
03

Conditions

postoperative painpostoperative abdominal discomfort

Beyond the preview

Go deeper on ChiCTR2500096318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500096318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call